CRL vs SLNO · rev $2.00B vs P/E 27, $2.76B cap
Charles River Laboratories (CRL) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
SLNO does not have a complete income-statement cache yet.
CRL currently screens at market cap $7.78B. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the CRL and SLNO stock pages for the full models.
Not investment advice.